Publication | Closed Access

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model

Pyridopyrimidine SeriesAntimicrobial SusceptibilityMedicinePseudomonas AeruginosaAntibacterial AgentMicrobiologyAntimicrobial CompoundPharmacophore ModelPharmacologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance